A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?
OBJECTIVE
To assess the definitions for "poor ovarian responders" used among randomized trials for the treatment of women with impaired response to stimulation.


METHODS
Systematic review.


METHODS
None.


METHODS
Poor ovarian responders.


METHODS
Treatment modalities for the management of poor ovarian responders.


METHODS
Number and nature of the criteria used to define poor ovarian response to stimulation and threshold values used.


RESULTS
Among 47 randomized trials, 41 different definitions for the patients with poor ovarian response have been used. No more than 3 trials used the same definition, whereas even trials from the same research groups used different definitions across different trials. None of the criteria used was adopted in more than 50% of the trials. Age and antral follicle count were adopted only in 9% of the definitions, whereas the criteria of number of follicles on the final stimulation day and number of oocytes retrieved were used in more than 40% of the trials; nonetheless, even for these criteria, the threshold values were consistently different.


CONCLUSIONS
The variability regarding the definition of poor ovarian responders appears to be striking. Although the Bologna criteria developed by European Society for Human Reproduction and Embryology consensus in 2011 aim to define a consistent group of patients, their applicability needs to be tested through clinical trials. Meanwhile, meta-analyses of the currently available trials should be strongly discouraged because they may lead to the adoption of interventions of ambiguous value.
Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium. n.polyzos@gmail.com
Nikolaos P
NP
Polyzos
Paul
P
Devroey
D019317:Evidence-Based Medicine / Q000592:standards; D005260:Female; D005300:Fertility Agents, Female / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007246:Infertility / Q000503:physiopathology / Q000628:therapy*; D010053:Ovary / Q000187:drug effects* / Q000503:physiopathology; D010060:Ovulation / Q000187:drug effects*; D010062:Ovulation Induction / Q000009:adverse effects / Q000379:methods; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic / Q000592:standards; D009626:Terminology as Topic; D017211:Treatment Failure
D005300:Fertility Agents, Female